Since PCa tumor growth is primarily driven by androgen receptor (AR) signaling, treatments include the use of drugs that decrease androgen synthesis or block binding of androgens to AR, called androgen deprivation therapy (ADT) [3,4]. Here, AR is linked to neoplasm.